Antibodies

Re:Cognition Health, the UK’s largest independent provider of Alzheimer’s disease-modifying treatments, announces the opening of its first Irish…

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells,…

Malaria kills more than half a million people a year, most of them young children in Africa. Two…

Announcing a new article publication for Zoonoses journal. This study was aimed at developing and preliminarily validating a…

New insights into lung-resident memory B cells show why the next generation of vaccines may need to protect…

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain…

COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 – the virus behind the most recent pandemic – but…

A new study from the University of Bergen shows an association between breastfeeding up to six months of…

Researchers have developed a chip-based metasurface biosensor that can detect traumatic brain injury (TBI) biomarkers at extremely low…

$Beta blockers reduce mortality and heart failure in MI patients with mildly reduced ejection fraction$

A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also…

Researchers identified an experimental antibody that targets a specific protein to shrink tumors in non-small cell lung cancer…

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the…

Re:Cognition Health launches first dedicated Alzheimer’s disease-modifying treatment clinic in Ireland